1. Home
  2. HGBL vs CRVO Comparison

HGBL vs CRVO Comparison

Compare HGBL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

HOLD

Current Price

$1.32

Market Cap

46.9M

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$4.00

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGBL
CRVO
Founded
1937
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.9M
47.7M
IPO Year
1998
2011

Fundamental Metrics

Financial Performance
Metric
HGBL
CRVO
Price
$1.32
$4.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$4.00
$21.50
AVG Volume (30 Days)
66.9K
79.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$20,129,000.00
$9,737,974.00
Revenue This Year
$16.03
N/A
Revenue Next Year
$5.33
N/A
P/E Ratio
$14.22
N/A
Revenue Growth
N/A
36.29
52 Week Low
$1.21
$1.92
52 Week High
$2.39
$16.50

Technical Indicators

Market Signals
Indicator
HGBL
CRVO
Relative Strength Index (RSI) 48.06 32.65
Support Level $1.24 N/A
Resistance Level $1.47 $5.44
Average True Range (ATR) 0.06 0.43
MACD -0.01 0.03
Stochastic Oscillator 61.29 23.35

Price Performance

Historical Comparison
HGBL
CRVO

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: